简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2023-02-10 18:03 Global Partners Announce Innovations for Marine Managers to Help Our Oceans With Private Sector Support From Mary Kay Inc.
2023-02-10 15:32 Takeda Completes Acquisition of Nimbus Therapeutics’ TYK2 Program Subsidiary
2023-02-10 14:16 Novaliq Plans to File a Markting Authorisation Application for CyclASol® in the E.U. for the Treatment of Dry Eye Disease in July 2023
2023-02-10 13:43 Dexcom and Nick Jonas Make Super Bowl Magic to Launch New Dexcom G7 Continuous Glucose Monitoring System
2023-02-10 10:17 Carbios appoints four new Board members to strengthen international expertise in brand development, business growth and scientific research
2023-02-09 13:37 Avania Acquires MAXIS, Advancing MedTech Leadership in Pre-Clinical, Regulatory Strategy, and Clinical Expertise
2023-02-09 09:49 IDC MarketScape Names Medidata a Leader in Life Science R&D Risk-Based Monitoring Solutions Vendor Assessment
2023-02-08 15:50 Parse Biosciences Announces Evercode TCR and Gene Capture
2023-02-08 11:10 U.S. FDA Approves Takeda’s TAKHZYRO® (lanadelumab-flyo) to Prevent Hereditary Angioedema (HAE) Attacks in Children 2 Years of Age and Older
2023-02-08 10:53 Accutar Biotechnology Announces FDA Clearance of IND Application for Phase 1 Trial of AC0676 in B-cell Malignancies
2023-02-07 19:05 KEMRI and NEC Announce Trials on Biometric-based Vaccination Management System for Newborn Children in Kenya
2023-02-07 19:01 Takeda Reinforces Long-term Growth Through Pipeline Advancement and Two Targeted Acquisitions; Delivers Another Strong Quarter in FY2022 Q3
2023-02-06 15:43 Dentalis Animal Health appoints Advisory Board
2023-02-06 10:19 Dexlevo’s GOURI Symposium and Brand Event at IMCAS 2023
2023-02-03 19:34 Exscientia Announces First-in-Human Study for Bristol Myers Squibb In-Licensed PKC Theta Inhibitor, EXS4318
2023-02-01 09:31 PMI Recognized in 2023 Bloomberg Gender-Equality Index for Third Consecutive Year
2023-01-31 10:43 Nemaura Medical Reports Initial Patient Data from UK NHS Miboko Study that Demonstrates Weight Loss in 100% of Participants
2023-01-30 18:08 Carbios Strengthens Executive Committee in Pivotal Year for Industrial and Commercial Development
2023-01-30 16:42 AGC Biologics Supports Commercial Production of Provention Bio’s New Type 1 Diabetes (T1D) Therapy, TZIELD™
2023-01-30 16:27 Spesolimab meets primary and key secondary endpoint for prevention of generalized pustular psoriasis flares